BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 29653607)

  • 1. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
    Knopman DS; Haeberlein SB; Carrillo MC; Hendrix JA; Kerchner G; Margolin R; Maruff P; Miller DS; Tong G; Tome MB; Murray ME; Nelson PT; Sano M; Mattsson N; Sultzer DL; Montine TJ; Jack CR; Kolb H; Petersen RC; Vemuri P; Canniere MZ; Schneider JA; Resnick SM; Romano G; van Harten AC; Wolk DA; Bain LJ; Siemers E
    Alzheimers Dement; 2018 Apr; 14(4):563-575. PubMed ID: 29653607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.
    Cummings J
    Alzheimers Dement; 2019 Jan; 15(1):172-178. PubMed ID: 29936146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.
    Carrillo MC; Dean RA; Nicolas F; Miller DS; Berman R; Khachaturian Z; Bain LJ; Schindler R; Knopman D;
    Alzheimers Dement; 2013 Sep; 9(5):594-601. PubMed ID: 24007744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease.
    Knopman DS; Siemers ER; Bain LJ; Hendrix JA; Carrillo MC
    Alzheimers Dement; 2018 Feb; 14(2):261-262. PubMed ID: 29413643
    [No Abstract]   [Full Text] [Related]  

  • 6. Common Alzheimer's Disease Research Ontology: National Institute on Aging and Alzheimer's Association collaborative project.
    Refolo LM; Snyder H; Liggins C; Ryan L; Silverberg N; Petanceska S; Carrillo MC
    Alzheimers Dement; 2012 Jul; 8(4):372-5. PubMed ID: 22748941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A standard model of Alzheimer's disease?
    Walker LC; Lynn DG; Chernoff YO
    Prion; 2018; 12(5-6):261-265. PubMed ID: 30220236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: The next frontier-Special Report 2017.
    Karlawish J; Jack CR; Rocca WA; Snyder HM; Carrillo MC
    Alzheimers Dement; 2017 Apr; 13(4):374-380. PubMed ID: 28314660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.
    Khachaturian ZS
    Alzheimers Dement; 2011 May; 7(3):253-6. PubMed ID: 21575869
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Sperling RA; Aisen PS; Beckett LA; Bennett DA; Craft S; Fagan AM; Iwatsubo T; Jack CR; Kaye J; Montine TJ; Park DC; Reiman EM; Rowe CC; Siemers E; Stern Y; Yaffe K; Carrillo MC; Thies B; Morrison-Bogorad M; Wagster MV; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):280-92. PubMed ID: 21514248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India.
    Huded CB; Bharath S; Chandra SR; Sivakumar PT; Varghese M; Subramanian S
    Asian J Psychiatr; 2015 Feb; 13():44-7. PubMed ID: 25468261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.
    Khachaturian AS; Hayden KM; Mielke MM; Tang Y; Lutz MW; Gustafson DR; Kukull WA; Mohs R; Khachaturian ZS
    Alzheimers Dement; 2018 Apr; 14(4):532-534. PubMed ID: 29653605
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alzheimer's Therapeutic Research Institute].
    Shimada H; Kato Y; Fujii H; Mori H
    Brain Nerve; 2017 Jul; 69(7):856-861. PubMed ID: 28740001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease.
    Visser PJ; Vos S; van Rossum I; Scheltens P
    Alzheimers Dement; 2012 Nov; 8(6):560-3. PubMed ID: 23102126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    McKhann GM; Knopman DS; Chertkow H; Hyman BT; Jack CR; Kawas CH; Klunk WE; Koroshetz WJ; Manly JJ; Mayeux R; Mohs RC; Morris JC; Rossor MN; Scheltens P; Carrillo MC; Thies B; Weintraub S; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):263-9. PubMed ID: 21514250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools?
    Snyder PJ; Kahle-Wrobleski K; Brannan S; Miller DS; Schindler RJ; DeSanti S; Ryan JM; Morrison G; Grundman M; Chandler J; Caselli RJ; Isaac M; Bain L; Carrillo MC
    Alzheimers Dement; 2014 Nov; 10(6):853-60. PubMed ID: 25458309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review.
    Ruthirakuhan M; Lanctôt KL; Di Scipio M; Ahmed M; Herrmann N
    Alzheimers Dement; 2018 Oct; 14(10):1344-1376. PubMed ID: 29940162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.